Anthem Blue Cross and Blue Shield | CommercialApril 1, 2020
Anthem prior authorization updates for specialty pharmacy are available
Prior authorization updates
Effective for dates of service on and after July 1, 2020, the following specialty pharmacy codes from current or new clinical criteria documents will be included in our prior authorization process.
Please note, inclusion of the National Drug Code (NDC) on your claim will shorten the claim processing time of drugs billed with a Not Otherwise Classified (NOC) code.
Access the clinical criteria document.
For Anthem Blue Cross and Blue Shield and affiliate HealthKeepers, Inc., prior authorization of these specialty pharmacy drugs will be managed by Anthem. Drugs used for the treatment of Oncology will still require pre-service clinical review by AIM Specialty Health® (AIM), a separate company.
Clinical Criteria |
HCPCS or CPT Code(s) |
Drug |
*ING-CC-0003 |
C9399 J3490 J3590 |
Xembify |
ING-CC-0062 |
J3590 |
Eticovo |
ING-CC-0062 |
J3490 |
Hadlima |
ING-CC-0072 |
J0179 |
Bevou |
ING-CC-0152 |
J3490 |
Vyondys 53 |
ING-CC-0153 |
C9399 J3490 J3590 |
Adakveo |
ING-CC-0154 |
C9399 J3490 J3590 |
Givlaari |
* Non-oncology use is managed by Anthem’s medical specialty drug review team; oncology use is managed by AIM.
Step-therapy updates
Effective for dates of service on and after July 1, 2020, the following specialty pharmacy codes from new or current clinical criteria will be included in our existing specialty pharmacy medical step-therapy review process.
Orencia will be the non-preferred agent for rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and psoriatic arthritis. The table below will assist you in identifying the applicable preferred agents and clinical criteria.
Access the clinical criteria document.
Rheumatoid Arthritis (RA) |
|||||
Clinical Criteria |
HCPCS or CPT Code |
Preferred Agents |
Clinical Criteria |
HCPCS or CPT Code |
Non-Preferred Agent |
ING-CC-0062 |
J1438 |
Enbrel |
ING-CC-0078 |
J0129 |
Orencia |
ING-CC-0062 |
J0135 |
Humira |
|||
ING-CC-0062 |
J3590 |
Simponi |
|||
ING-CC-0062 |
J1602 |
Simponi Aria |
|||
ING-CC-0062 |
J1745 |
Remicade |
Polyarticular Juvenile Idiopathic Arthritis (PJIA) |
|||||
Clinical Criteria |
HCPCS or CPT Code |
Preferred Agents |
Clinical Criteria |
HCPCS or CPT Code |
Non-Preferred Agent |
ING-CC-0062 |
J1438 |
Enbrel |
ING-CC-0078 |
J0129 |
Orencia |
ING-CC-0062 |
J0135 |
Humira |
Psoriatic Arthritis (PsA) |
|||||
Clinical Criteria |
HCPCS or CPT Code |
Preferred Agents |
Clinical Criteria |
HCPCS or CPT Code |
Non-Preferred Agent |
ING-CC-0042 |
C9399 J3490 J3590 |
Cosentyx |
ING-CC-0078 |
J0129 |
Orencia |
ING-CC-0062 |
J1438 |
Enbrel |
|||
ING-CC-0062 |
J0135 |
Humira |
|||
ING-CC-0062 |
J3590 |
Simponi |
|||
ING-CC-0062 |
J1602 |
Simponi Aria |
|||
ING-CC-0062 |
J1745 |
Remicade |
|||
ING-CC-0063 |
J3357 |
Stelara |
PUBLICATIONS: April 2020 Anthem Provider News - Virginia
To view this article online:
Or scan this QR code with your phone